Medtronic Inc., which is preparing to complete a $43 billion merger with Covidien PLC, said its revenue increased 4.1% in the quarter ending in October, even as competitive pressures weighed on sales of two important product lines. . The merger, combining two of the world’s largest surgical-implant and hospital-supply companies, remains on schedule to close in early 2015, Chief Executive Omar Ishrak said on a conference call with analysts. The companies plan to hold a special meeting in January to seek shareholder approval...
  